Skip to main content

Table 4 Characteristics at baseline and after 12 months in the vitamin D and placebo group

From: Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months

  Vitamin D group*______________________________ Placebo group______________________________
Baseline 12 months Baseline 12 months
N 40 40 37 37
Age (years) 48.9 ± 10.0   51.0 ± 10.1  
Smokers (%) 20.0   18.9  
BMI (kg/m2) 34.4 ± 4.2 34.5 ± 4.5 34.3 ± 3.1 34.5 ± 3.5
Systolic blood pressure (mmHg) 130.7 ± 13.6 136.2 ± 16.9 130.9 ± 16.1 131.6 ± 16.6
Diastolic blood pressure (mmHg) 81.5 ± 10.8 84.1 ± 10.5 79.4 ± 10.5 80.3 ± 8.9
HbA1c (%) 5.62 ± 0.40 5.74 ± 0.40 5.74 ± 0.42 5.80 ± 0.46
Serum PTH (pmol/L) 5.63 ± 1.60 4.64 ± 1.55a 5.79 ± 1.81 5.66 ± 2.06
Serum 25(OH)D (nmol/L) 50.2 ± 14.2 101.7 ± 17.8a 53.0 ± 19.1 49.6 ± 16.0
  1. *19 subjects given 20.000 IU and 21 subjects given 40.000 IU vitamin D3 per week. a P <0.01 versus baseline in the vitamin D group and versus 12 months values in the placebo group; t-tests. Values are mean ± SD